Pre-market Hot Trades in US Stocks

Vivakor is down 7.48% in pre-market trading. Based on recent key news:

1. On July 29, Vivakor updated its crude oil marketing platform guidance, expecting annual commercial activity to reach approximately $1.5 billion. This news drove the stock price up over 200% during trading. Source: Reuters

2. On July 27, Vivakor advanced the commercial operation of its Houston oil remediation processing center. This move is seen as an important step towards the company's operational goals and may have a positive impact on its financial performance. Source: Reuters

3. On July 29, the company's Chief Financial Officer Kimberly Hawley was appointed as the interim Chief Financial Officer of Olenox, causing the stock price to surge during trading. Source: Reuters The energy sector is volatile, and market sentiment is cautious.

Vertiv is up 4.68% in pre-market trading. Based on recent key news:

1. On July 29, Vertiv announced its second-quarter financial report, with sales of $3.274 billion falling short of the market expectation of $3.377 billion, but adjusted earnings per share of $1.52 exceeded the expected $1.42. This news led to stock price fluctuations.

2. On July 29, Vertiv raised its full-year performance guidance, expecting adjusted earnings per share of $6.65 to $6.75 for 2026, an increase from previous guidance, reflecting improved demand in the data center market.

3. On July 30, Vertiv announced a partnership with VisionBay AI to advance the 800 VDC power architecture validation at the Kaohsiung K1 AI data center, showcasing the company's strategic layout in the AI infrastructure field. Strong demand for data centers is driving industry growth.

Top Gainers in Pre-market US Stocks

Nuwellis is up 120.65% in pre-market trading. Based on recent key news:

1. On July 27, Nuwellis announced preliminary revenue results for the second quarter of 2026, showing a year-on-year growth of 14%. This growth is mainly attributed to the commercial success of the Aquadex ultrafiltration platform, driving the stock price significantly higher.

2. On July 27, Nuwellis announced a preliminary revenue growth of 20% year-on-year for the first half of 2026. This news further boosted market confidence, leading to continued stock price increases.

3. On July 27, Nuwellis plans to release its complete financial results for the second quarter of 2026 on August 13. Investors have positive expectations and are buying in advance, driving the stock price up. The market is optimistic about the performance of the medical technology industry, with significant capital inflow.

T3 Defense is up 99.72% in pre-market trading. Based on recent key news:

1. On July 29, T3 Defense completed a 1-for-125 reverse stock split, reducing the float to 1.12 million shares, triggering a technical short squeeze. At the same time, the company made progress in its Project 35 in the anti-drone technology field and achieved contract delivery, further boosting market confidence

2. On July 28, T3 Defense's subsidiary completed the delivery of an automated composite material production line worth $1.1 million, expanding the company's influence in the high-demand anti-drone technology sector.

3. On July 28, X S.E. Security and Defense Ltd. acquired a 16.67% stake in T3 Defense in exchange for Project 35 equity, and the strategic investment news boosted investor confidence. The demand for anti-drone technology has increased, and the market is active.

China Su Xuan Tang Pharmaceutical, pre-market up 42.10%, has no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation